Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Stem Cell Transplantation With Alternative Donor in Treatment of Hematologic Malignancy

NCT02487069 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT02487069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02487069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Stem Cell Transplantation With Alternative Donor in Treatment of Hematologic Malignancy
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2015
Completion date
February 29, 2020
Enrollment
876 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia, chronic myeloid leukemia, myelodysplastic syndrome